Multiple myeloma remains a significant challenge in hematology due to its high disease burden and incurable nature. A premalignant state known as monoclonal gammopathy of undetermined significance (MGUS) consistently precedes this malignancy. While clinicians recognize various risk factors, the exact contribution of modifiable variables to the progression of MGUS to multiple myeloma has remained largely unquantified. A recent retrospective cohort study involving 35,073 U.S. Veterans has provided critical insights into these underlying factors.

Understanding Risk Factors in MGUS to Multiple Myeloma Progression

The study researchers analyzed multivariable-adjusted population attributable fractions (aPAF) to determine the impact of specific factors on disease progression. Specifically, they identified excess body mass index (BMI ≥25 kg/m²) as the most significant modifiable factor. In this large cohort, excess BMI accounted for 27.1% of the statistical burden of progression across all racial groups. Consequently, these results suggest that nearly one-fourth of progression cases might be avoided through effective weight management. Additionally, the study noted that both Black and White Veterans shared similar aPAF values for BMI, highlighting the universal impact of obesity.

In addition to BMI, other factors like chemical exposure and comorbidities were evaluated. However, weight management emerged as the most actionable clinical intervention. For Indian clinicians, these findings are particularly relevant because multiple myeloma often presents a decade earlier in Indian patients compared to Western populations. Therefore, integrating lifestyle counseling into the routine follow-up of MGUS patients may improve long-term outcomes. Furthermore, maintaining a healthy weight might serve as a primary prevention strategy for those at high risk. Specifically, aggressive monitoring of patients with a BMI over 25 could help mitigate the rising incidence of plasma cell dyscrasias.

Frequently Asked Questions

Which modifiable risk factor most significantly impacts MGUS progression?

According to recent data, excess body mass index (BMI ≥25 kg/m²) is the leading modifiable factor, contributing to approximately 27.1% of cases where MGUS progresses to multiple myeloma.

What is the clinical significance of Population Attributable Fraction (aPAF) in this context?

The aPAF estimates the proportion of disease progression in the MGUS population that is statistically attributable to a specific risk factor. It helps clinicians prioritize interventions that could theoretically prevent the highest number of cases.

Should MGUS patients in India focus on weight management?

Yes. Since Indian patients often develop multiple myeloma at a younger age, managing modifiable risks like obesity through diet and lifestyle modification is a vital part of comprehensive care.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.

References

Wang M et al. Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population. Int J Cancer. 2026 Mar 11. doi: 10.1002/ijc.70412. PMID: 41813601.

Kyle RA, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives. Leukemia. 2010;24(6):1121-1127.

Kumar R, et al. Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study. Clin Lymphoma Myeloma Leuk. 2018;18(9):e355-e360.